Page 11 - Veena Mani

Labour pangs for surrogacy law

The central govt has drafted a law to restrict wombs for hire, and there is much to be said on all sides, with criticism that it steps on too many hopes

Pricing norms outdated, says NPPA chief

Bhupendra Singh also says DPCO also needs to be suitably tp help drug price controller fix the price of coronary stents

No bulk drug policy: Ananth Kumar

The chemical and fertilizers minister said govt decided against a bulk drug policy

Draft surrogacy Bill draws flak from health care industry

Dr Lal PathLabs faces pricing pressure, margin erosion

In its annual report, the company raised concerns of pricing control at the time of epidemics

NephroPlus raises Rs 100 cr in series C funding

The company plans to open 400 more centres in the next five years, primarily through partnership with hospitals

Draft Bill to ban commercial surrogacy

Aims to completely ban commercial surrogacy but permitting 'altruistic' surrogacy under strict rules

MNCs, domestic firms at odds over stent pricing

MNCs say any special price for stents should be granted on clinical proof of the products being superior

Don't bring a drug under price control because it's widely sold: Shailesh Ayyangar

Interview with Managing Director, Sanofi India

Morepen to go big on therapies for preventive cardiology & diabetology

To expand its services in the diagnostics and therapy segment in the coming years

Morepen set to go big on therapies for preventive cardiology, diabetology

Prices of HIV, asthma, malaria drugs revised

Include tablets such as Efavirenz, Ibuprofen, Tamoxifen and Salbutamol, Phenobarbitone injection and Rifampicin capsule

Drug firms expect rebound in domestic biz

Firms faced pressure in first quarter due to price cap and drug ban

Cabinet note being readied on health care for poor

Health ministry officials said the government would soon start empanelling hospitals

Non-compliance with global norms a risk: Alembic

The company is debt-free and is positive that it will help it mobilise funds at low costs from external sources to implement its capital expenditure plans

Laxachem Organics under import alert

Laxachem manufactures active pharmaceutical ingredient for repackagers, labelers, and wholesale drug distributors

Health care benefits may come from a mix of schemes

Rs 1-lakh payout towards health care costs of poor families will come from a combination of the schemes run by states and the Centre's Rashtriya Swasthya Bima Yojana

Rules eased to import, export human biological samples

Wockhardt Q1 net profit dives 80% to Rs 16 cr

The India business of the company grew a marginal 10 per cent, despite launching 11 new products in the market

Sun Pharma Q1 net zooms over 3-fold at Rs 2,034 cr on strong US sales

Overall consolidated revenue grew 23% to Rs 8,007 cr